Clinical Trial Update: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a combination chemotherapy regimen for stage III epithelial ovarian cancer and primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | Status: COMPLETED